12 structures "https:" "https:" "https:" "https:" "https:" "https:" "Imperial College London" Postdoctoral positions at University of Basel in Switzerland
Sort by
Refine Your Search
-
Clinical Practice (GCP) or willingness to obtain further training High level of self-motivation and a very independent, structured working style Very good command of English and at least basic knowledge of
-
We will begin reviewing applications on 5 January 2026 and will accept applications for as long as this posting is available online. Further Information: Marketing group: https://wwz.unibas.ch/de
-
cancer and metabolism. For a summary see: https://p3.snf.ch/project-204602 . ii) investigating of the role of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity, diabetes and
-
starting date is 1st August 2026. If you have any questions, please contact Dr. Fabian Baumann (fabian.baumann@unibas.ch ). You can also find out more about us at https://dg.philhist.unibas.ch/de/ . Where
-
. Arsham Hamidi (arsham.hamidi@unibas.ch ) if you have further questions: • CV including publication list • Diplomas • Motivation letter (max 2 pages) Want to know more about us? Check out https
-
We will begin reviewing applications on 5 January 2026 and will accept applications for as long as this posting is available online. Further Information: Marketing group: https://wwz.unibas.ch/de
-
of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity, diabetes and cancer; see https://p3.snf.ch/project-189065 ii) developing and validation of novel chemical probes and degraders
-
the lab, and at the same time to play an active role in shaping and creating an inspiring research and working environment. In line with our and Uni Basel values (https://www.unibas.ch/en/Research/Values
-
This project is flanked by basic reasearch projects i) developing novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism. For a summary see: https://p3.snf.ch
-
, diabetes and cancer; see https://p3.snf.ch/project-189065 ii) developing and validation of novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism. For a summary